JEL2603

JEL2603 is a peptide drug candidate developed by Carocell Bio. It is designed as a safe, convenient, and efficacious topical alternative to existing injected biologics for inflammatory diseases. The primary focus of development is for inflammatory bowel disease (IBD), where it aims to provide both flare treatment and long-term maintenance therapy. JEL2603 is formulated as a topical gel, offering an alternative route of administration compared to current injectable therapies. Its mechanism of action has not been explicitly detailed in public sources, but it is positioned as an anti-inflammatory agent targeting chronic inflammation in the digestive tract[1][2].